Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Universal ivermectin prophylaxis for strongyloidiasis in patients receiving high-dose corticosteroids
TCTR20221115001Completed
- Sponsor
- N/A
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ivermectin in strongyloidiasis, sponsored by N/A. Started Dec 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
strongyloidiasis
Beyond the preview
Go deeper on TCTR20221115001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221115001.